NRAS-话题@MedSci - 梅斯（MedSci）

#NRAS#

11篇内容 | 1156人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2079848, encodeId=01f220e984883, content=<a href='/topic/show?id=8b5e1302933' target=_blank style='color:#2F92EE;'>#NRAS#</a>, objectTitle=Clin Cancer Res：比美替尼联合瑞博西林治疗NRAS突变的黑色素瘤, objectType=article, longId=301035, objectId=dece30103500, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dece30103500, replyNumber=0, likeNumber=96, createdTime=2022-04-02, rootId=0, userName=tcm99hq, userId=74c2229, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dece30103500, moduleTitle=Clin Cancer Res：比美替尼联合瑞博西林治疗NRAS突变的黑色素瘤, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=dece30103500)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2079847, encodeId=73c820e984747, content=<a href='/topic/show?id=8b5e1302933' target=_blank style='color:#2F92EE;'>#NRAS#</a>, objectTitle=Eur J Cancer：MEK抑制剂治疗NRAS突变型转移性黑色素瘤的真实临床疗效, objectType=article, longId=300803, objectId=cb143008036b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb143008036b, replyNumber=0, likeNumber=107, createdTime=2023-01-31, rootId=0, userName=tcm99hq, userId=74c2229, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb143008036b, moduleTitle=Eur J Cancer：MEK抑制剂治疗NRAS突变型转移性黑色素瘤的真实临床疗效, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=cb143008036b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2079846, encodeId=862820e98463e, content=<a href='/topic/show?id=8b5e1302933' target=_blank style='color:#2F92EE;'>#NRAS#</a>, objectTitle=Cell:华人大拿再发力，揭秘NRAS突变黑色素瘤新机制！, objectType=article, longId=160958, objectId=d15316095898, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d15316095898, replyNumber=0, likeNumber=79, createdTime=2020-01-17, rootId=0, userName=tcm99hq, userId=74c2229, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d15316095898, moduleTitle=Cell:华人大拿再发力，揭秘NRAS突变黑色素瘤新机制！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d15316095898)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2079844, encodeId=11cd20e9844ee, content=<a href='/topic/show?id=8b5e1302933' target=_blank style='color:#2F92EE;'>#NRAS#</a>, objectTitle=Lancet Gastroen Hepatol：BRAF， PIK3CA， KRAS以及 NRAS野生型晚期或转移性结直肠癌患者多信号通路联合治疗研究, objectType=article, longId=123846, objectId=166d123846a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=166d123846a2, replyNumber=0, likeNumber=77, createdTime=2018-07-02, rootId=0, userName=tcm99hq, userId=74c2229, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=166d123846a2, moduleTitle=Lancet Gastroen Hepatol：BRAF， PIK3CA， KRAS以及 NRAS野生型晚期或转移性结直肠癌患者多信号通路联合治疗研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=166d123846a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2079845, encodeId=8a9620e9845ec, content=<a href='/topic/show?id=8b5e1302933' target=_blank style='color:#2F92EE;'>#NRAS#</a>, objectTitle=EUR J Cancer：657例黑色素瘤患者NRAS的增益分析并评估其对MEK抑制剂的敏感性, objectType=article, longId=124480, objectId=bca6124480a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bca6124480a4, replyNumber=0, likeNumber=72, createdTime=2018-04-13, rootId=0, userName=tcm99hq, userId=74c2229, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bca6124480a4, moduleTitle=EUR J Cancer：657例黑色素瘤患者NRAS的增益分析并评估其对MEK抑制剂的敏感性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=bca6124480a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2079843, encodeId=98b320e98438c, content=<a href='/topic/show?id=8b5e1302933' target=_blank style='color:#2F92EE;'>#NRAS#</a>, objectTitle=Br J Dermatol：后天性黑素细胞痣的BRAF和NRAS突变, objectType=article, longId=111592, objectId=e562111592de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e562111592de, replyNumber=0, likeNumber=65, createdTime=2018-06-12, rootId=0, userName=tcm99hq, userId=74c2229, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e562111592de, moduleTitle=Br J Dermatol：后天性黑素细胞痣的BRAF和NRAS突变, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e562111592de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2079842, encodeId=7b3720e9842df, content=<a href='/topic/show?id=8b5e1302933' target=_blank style='color:#2F92EE;'>#NRAS#</a>, objectTitle=CLIN CANCER RES：NRAS突变结直肠癌患者临床特征及结局, objectType=article, longId=111132, objectId=0c48111132a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0c48111132a1, replyNumber=0, likeNumber=107, createdTime=2017-11-08, rootId=0, userName=tcm99hq, userId=74c2229, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0c48111132a1, moduleTitle=CLIN CANCER RES：NRAS突变结直肠癌患者临床特征及结局, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0c48111132a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2079841, encodeId=d59320e9841e6, content=<a href='/topic/show?id=8b5e1302933' target=_blank style='color:#2F92EE;'>#NRAS#</a>, objectTitle=Br J Dermatol：后天性黑素细胞痣的BRAF和NRAS突变提示MAPK信号通路的激活, objectType=article, longId=106540, objectId=37c5106540e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=37c5106540e8, replyNumber=0, likeNumber=78, createdTime=2018-04-25, rootId=0, userName=tcm99hq, userId=74c2229, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=37c5106540e8, moduleTitle=Br J Dermatol：后天性黑素细胞痣的BRAF和NRAS突变提示MAPK信号通路的激活, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=37c5106540e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2079840, encodeId=741320e984091, content=<a href='/topic/show?id=8b5e1302933' target=_blank style='color:#2F92EE;'>#NRAS#</a>, objectTitle=ARCH PATHOL LAB MED：NRAS Q61R突变体特异性免疫组化在结直肠癌诊断中的意义, objectType=article, longId=99626, objectId=d48d996264c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d48d996264c, replyNumber=0, likeNumber=83, createdTime=2018-01-02, rootId=0, userName=tcm99hq, userId=74c2229, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d48d996264c, moduleTitle=ARCH PATHOL LAB MED：NRAS Q61R突变体特异性免疫组化在结直肠癌诊断中的意义, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d48d996264c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2079839, encodeId=88e020e983988, content=<a href='/topic/show?id=8b5e1302933' target=_blank style='color:#2F92EE;'>#NRAS#</a>, objectTitle=JAMA Oncology：NRAS和BRAF突变与高危型原发黑色素瘤生存期的关系, objectType=article, longId=49384, objectId=e11b4938401, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e11b4938401, replyNumber=0, likeNumber=86, createdTime=2016-03-01, rootId=0, userName=tcm99hq, userId=74c2229, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e11b4938401, moduleTitle=JAMA Oncology：NRAS和BRAF突变与高危型原发黑色素瘤生存期的关系, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e11b4938401)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2079838, encodeId=8bc520e9838f5, content=<a href='/topic/show?id=8b5e1302933' target=_blank style='color:#2F92EE;'>#NRAS#</a>, objectTitle=PNAS：报道明星癌基因NRAS的4个新亚型, objectType=article, longId=33154, objectId=96ca33154be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=96ca33154be, replyNumber=0, likeNumber=83, createdTime=2015-02-07, rootId=0, userName=tcm99hq, userId=74c2229, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=96ca33154be, moduleTitle=PNAS：报道明星癌基因NRAS的4个新亚型, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=96ca33154be)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

NRAS

2020-05-29

tcm99hq (审核中...)

前往app查看评论内容

#NRAS#

Clin Cancer Res：比美替尼联合瑞博西林治疗NRAS突变的黑色素瘤

2022-04-02

tcm99hq (审核中...)

前往app查看评论内容

#NRAS#

Eur J Cancer：MEK抑制剂治疗NRAS突变型转移性黑色素瘤的真实临床疗效

2023-01-31

tcm99hq (审核中...)

前往app查看评论内容

#NRAS#

Cell:华人大拿再发力，揭秘NRAS突变黑色素瘤新机制！

2020-01-17

tcm99hq (审核中...)

前往app查看评论内容

#NRAS#

Lancet Gastroen Hepatol：BRAF， PIK3CA， KRAS以及 NRAS野生型晚期或转移性结直肠癌患者多信号通路联合治疗研究

2018-07-02

tcm99hq (审核中...)

前往app查看评论内容

#NRAS#

EUR J Cancer：657例黑色素瘤患者NRAS的增益分析并评估其对MEK抑制剂的敏感性

2018-04-13

tcm99hq (审核中...)

前往app查看评论内容

#NRAS#

Br J Dermatol：后天性黑素细胞痣的BRAF和NRAS突变

2018-06-12

tcm99hq (审核中...)

前往app查看评论内容

#NRAS#

CLIN CANCER RES：NRAS突变结直肠癌患者临床特征及结局

2017-11-08

tcm99hq (审核中...)

前往app查看评论内容

#NRAS#

Br J Dermatol：后天性黑素细胞痣的BRAF和NRAS突变提示MAPK信号通路的激活

2018-04-25

tcm99hq (审核中...)

前往app查看评论内容

#NRAS#

ARCH PATHOL LAB MED：NRAS Q61R突变体特异性免疫组化在结直肠癌诊断中的意义

2018-01-02

tcm99hq (审核中...)

前往app查看评论内容

#NRAS#

JAMA Oncology：NRAS和BRAF突变与高危型原发黑色素瘤生存期的关系

2016-03-01

tcm99hq (审核中...)

前往app查看评论内容

#NRAS#

PNAS：报道明星癌基因NRAS的4个新亚型

2015-02-07

科室
- - 订阅+
  - 更多科室
工具
服务